New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do…
Psychedelics News
Psychedelics are a class of psychoactive substances that produce profound changes in perception, mood, and cognitive processes. These substances, which include LSD, psilocybin (found in magic mushrooms), and DMT, have been used for thousands of years, often in religious or spiritual contexts. Modern interest in psychedelics surged in the mid-20th century, leading to extensive research into their potential therapeutic effects. However, the legal status of these substances became restricted under international conventions in the 1970s, greatly limiting their scientific study. In recent years, there has been a resurgence of interest in the potential of psychedelics to treat various mental health disorders such as depression, PTSD, and anxiety, with numerous clinical trials showing promising results. This has led to a reevaluation of their legal status and increased funding for psychedelic research in several countries.
Psychedelic Surprise: What’s Really in Your Brain Health Gummies?
Mushroom gummies marketed for brain health have been found to contain illegal psilocybin and other dangerous ingredients. UVA Health’s research reveals these risks following multiple…
Tiny Doses, Massive Interest: 1250% Surge in Microdosing As Drug Laws Evolve
New research highlights a significant increase in interest in microdosing, with a 1250% rise in related searches over eight years, correlating with major policy changes…
Magic Mushrooms and the Mind: Psilocybin’s Hyperconnected Brain State Linked to Therapeutic Effects
Study shows psilocybin induces dynamic brain connectivity, linked to profound, ego-altering experiences, potentially beneficial in psychotherapy. Researchers have discovered that psilocybin, the active compound in…
Magic Mushrooms Show Potency Against Depression
Findings are encouraging but further evidence is needed before any clinical recommendations can be made, say experts. Psilocybin — the active ingredient in “magic” mushrooms…
Decoding Psilocybin: “Magical” Enzymatic Pathways to Psychiatric Breakthroughs
New study sheds light on the structure and evolution of an enzyme in psychoactive fungi. The psychoactive substance psilocybin is the most important natural product…
Ketamine Unlocked: Rapid Depression Relief Meets Long-Term Recovery
Discovery opens door to developing non-toxic fast and sustained-effect antidepressants. ‘Ketamine alongside conventional antidepressants could amplify therapeutic effects’ A fast-acting antidepressant ‘is enormously helpful for…
Transforming Lives: Psilocybin’s Remarkable Effect on Cancer-Related Depression
Clinical trial results support further study of this psychedelic substance, administered with psychological support from trained therapists, in affected patients. Results from a phase II…
Nasal Spray Demonstrates Significant Success in Treating Depression
Severe depression and treatment-resistant depression (TRD) are prevalent conditions. About one-third of patients show no improvement with standard treatments like selective serotonin reuptake inhibitors (SSRIs)…
Ketamine Nasal Spray: A Game-Changer for Treatment-Resistant Depression?
Increases the number of patients likely to respond to treatment for major depression. A major clinical trial shows that the drug, esketamine, one of the…
Rapid Relief: Ketamine’s Surprisingly Swift Treatment of PTSD and Depression
Recent research indicates that ketamine, traditionally an anesthetic, can quickly reduce PTSD and depression symptoms. This finding is significant given the slow onset of traditional…
Mind-Bending Medicine: The Psychedelic Depression Breakthrough
Journal of Psychiatric Practice presents review and update on psychedelics for mental disorders. A growing body of evidence suggests that psychedelic drugs may be useful…
Rapid Brain Transformation: Neurological Insights Into Psychedelic-Assisted Psychotherapy
Although the brain’s capacity for change is usually slow, it can be rapidly enhanced through psychedelic-assisted psychotherapy. Using substances like psilocybin, this therapy induces significant…
Stanford Study Uncovers Surprising Twist in Ketamine’s Effect on Depression
In an unusual trial, Stanford Medicine researchers found that a patient’s belief that they had received ketamine, even if they didn’t, could improve their depression….
Psychedelic Science: How Microdosing Magic Mushrooms Might Mend the Mind
Studies on rats provide insight into how microdosing of psychedelic mushrooms may be used for therapeutic treatment in humans. A new research result from the…
Ketamine’s Triumph Over Depression: Clinical Trial Results
A recent trial shows a low-cost version of ketamine effectively treats severe depression, with over 20% of participants achieving total remission. The cost-effective treatment could…
Esketamine Nasal Spray: A Game-Changing Treatment for Clinical Depression
Esketamine has showcased promising results in a major clinical trial, proving more effective than standard treatments for treatment-resistant depression. Treatment-resistant depression (TRD) is a particularly…
“People Have To Be Careful” – Scientists Debunk Claims of a Psychedelic Cannabinoid
UB researchers advise caution as THC-O-acetate garners increased interest. The cannabis plant is complex, containing roughly 100 cannabinoids or chemical compounds, many of which remain…